男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

China still to fully reimburse cost for COVID treatment

By Li Lei | chinadaily.com.cn | Updated: 2023-01-07 16:08
Share
Share - WeChat
A medical worker in a protective suit adjusts a monitoring device for a patient at the fever clinics of the Third Hospital of Hebei Medical University. [Photo by Wang Zhuangfei/China Daily]

Hospitalization cost for COVID-19 patients will continue to be fully reimbursed until the end of March, a circular said on Saturday, despite China's decision to downgrade the disease' management from Class A to Class B on Sunday.

Released by four departments including the National Healthcare Security Administration and the Ministry of Finance, the circular said hospitalization costs that confirm to the diagnosis and treatment plan for novel coronavirus infections -- as COVID-19 is officially known -- will still be reimbursed as before.

The costs will be shared between several State-run healthcare plans -- such as the country's basic medical insurance and the issuance for severe illnesses -- and local finance authorities, the circular said.

It added that 60 percent of the spending by local government will be later paid by the central finance authorities.

To ease pressure for top hospitals, the circular said patients seeking medical advice at Grade 1 hospitals, or the grassroots medical institutions such as township hospitals, will have at least 70 percent of their spending covered by the State. The exact ratio will be decided by local medical insurance and finance departments in light of local balancing situations.

The medical fees incurred by COVID-19 patients at other higher level hospitals will be the same with other Class B infectious diseases, which has a threshold and a cap for reimbursement, it said.

Places facing a shortage of medications are allowed to add more drugs to the catalog of reimbursable medicines.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 泰兴市| 施秉县| 怀宁县| 武鸣县| 通化县| 乌兰察布市| 安远县| 桐柏县| 吉首市| 淄博市| 卢湾区| 广昌县| 福清市| 平舆县| 苍山县| 芜湖县| 斗六市| 保定市| 玛多县| 大足县| 分宜县| 靖宇县| 万盛区| 抚顺县| 宣武区| 资中县| 板桥市| 怀化市| 罗平县| 共和县| 宁城县| 萨嘎县| 巴青县| 松桃| 平乡县| 芜湖市| 汤原县| 贵定县| 大同县| 虎林市| 杭州市|